Transaction in Own Shares

Summary by AI ^BETAClose X

Melrose Industries PLC has announced the purchase of 367,874 of its ordinary shares between May 18th and May 22nd, 2026, through Merrill Lynch International. The volume-weighted average price for these purchases ranged from 481.3305 pence to 507.3798 pence per share. Following these transactions, the company now holds 64,790,726 shares in treasury, with 1,246,684,595 ordinary shares remaining in issue.

Disclaimer*

Melrose Industries PLC

26 May 2026


26ᵗʰ May 2026
Melrose Industries PLC
("Melrose" or the "Company")
Transaction in Own Shares

The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 18ᵗʰ May 2026 to 22ⁿᵈ May 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (pence)	Highest price per share (p)
18 May 2026	XLON	481.3305	67,000	469.4000	486.9000
19 May 2026	XLON	487.2202	65,874	483.0000	495.2000
20 May 2026	XLON	495.4978	66,000	482.5000	507.4000
21 May 2026	XLON	500.6717	63,000	497.3000	510.2000
22 May 2026	XLON	507.3798	65,000	499.8000	510.4000


The Company intends to hold the purchased shares in treasury.

Following the above transaction, the Company has 64,790,726 ordinary shares in treasury and has 1,246,684,595 ordinary shares in issue (excluding treasury shares).


Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/5381F_1-2026-5-22.pdf

For further information please contact:
Warren Fernandez Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END